
Pharmaceuticals in Mexico
Description
Pharmaceuticals in Mexico
Summary
Pharmaceuticals in Mexico industry profile provides top-line qualitative and quantitative summary information including: market size (value 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values refer to the value generated by market players.
- The Mexican pharmaceuticals market registered revenues of $17.7 billion in 2023, representing a compound annual growth rate (CAGR) of 7% between 2018 and 2023.
- Mexico captured a share of 2.9% in the American pharmaceuticals market, in 2023.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Mexico
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Mexico
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Mexico pharmaceuticals market with five year forecasts
- What was the size of the Mexico pharmaceuticals market by value in 2023?
- What will be the size of the Mexico pharmaceuticals market in 2028?
- What factors are affecting the strength of competition in the Mexico pharmaceuticals market?
- How has the market performed over the last five years?
- What are the main segments that make up Mexico's pharmaceuticals market?
Table of Contents
35 Pages
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Geography segmentation
- 1.4. Market rivalry
- 1.5. Competitive landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 4 Market Segmentation
- 4.1. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Who are the leading players?
- 7.2. What strategies do leading players follow?
- 7.3. What are the recent developments in the market?
- 8 Company Profiles
- 8.1. Bayer de Mexico SA de CV
- 8.2. Boehringer Ingelheim Mexico
- 8.3. Sanofi-Aventis de Mexico SA de CV
- 8.4. Genomma Lab Internacional SAB de CV
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. Industry associations
- 10.3. Related MarketLine research
- 10.4. About MarketLine
- List of Tables
- Table 1: Mexico pharmaceuticals market value: $ billion, 2018-23
- Table 2: Mexico pharmaceuticals market geography segmentation: $ billion, 2023
- Table 3: Mexico pharmaceuticals market value forecast: $ billion, 2023-28
- Table 4: Bayer de Mexico SA de CV: Key Facts
- Table 5: Bayer de Mexico SA de CV: Key Employees
- Table 6: Boehringer Ingelheim Mexico: Key Facts
- Table 7: Boehringer Ingelheim Mexico: Key Employees
- Table 8: Sanofi-Aventis de Mexico SA de CV: Key Facts
- Table 9: Genomma Lab Internacional SAB de CV: Key Facts
- Table 10: Genomma Lab Internacional SAB de CV: Annual Financial Ratios
- Table 11: Genomma Lab Internacional SAB de CV: Key Employees
- Table 12: Mexico Size of Population (million), 2019-23
- Table 13: Mexico Real GDP (constant 2010 prices, $ billion), 2019-23
- Table 14: Mexico GDP (current prices, $ billion), 2019-23
- Table 15: Mexico Inflation, 2019-23
- Table 16: Mexico Consumer Price Index (absolute), 2019-23
- Table 17: Mexico Exchange Rate, 2018-23
- List of Figures
- Figure 1: 220 Laboratories Inc: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
- Figure 2: 220 Laboratories Inc: Private Equity and Ownership Volume and Value Trend (2020 - YTD*2024)
- Figure 3: 220 Laboratories Inc: Private Equity and Ownership Volume by Deal Type (2020 - YTD*2024)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.